06:28 AM EST, 11/04/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) reported a Q3 loss Monday of $0.60 per diluted share, compared with a loss of $0.68 a year earlier.
Analysts polled by Capital IQ expected a loss of $0.64 per share.
As expected, no revenue was reported for the quarter ended Sept. 30.
At the end of the quarter, the company said it had $1.2 billion in cash and cash equivalents on hand, which it expects could fund operations through at least 2028.